Fred Ehrsam is the CEO and Co-founder of Nudge, whose mission is to build the most capable whole brain/computer interface in the world, starting with non-invasive ultrasound to solve acute medical conditions like opioid addiction and chronic pain. In addition to Nudge, Fred is a significant funder of cutting edge biotech startups and researchers spanning everything from assisted reproductive technologies to longevity and new AI models for protein folding and drug discovery. He hosts the Prometheus Summit which brings together top researchers and scientists in the field.

Prior to Nudge, Fred co-founded two category leading companies: Coinbase (NASDAQ: $COIN) and Paradigm. Fred started his career at Goldman Sachs in New York and holds a B.S. in Computer Science and Economics with honors and distinction from Duke University. He was named to TIME Magazine's list of 30 People Under 30 Changing the World.